[ad_1]
The Ministry of Health announced Thursday (3) the incorporation of sapropterin dihydrochloride, used in the treatment of phenylketonuria unified health system (SUS). The remedy must be available on the public network within 180 days and will be offered to women in pre-conception or during the gestation period and who have obtained a positive result to the drug.
According to the record, the use of sapropterin dihydrochloride for the treatment of phenylketonuria is complementary to the diet, limiting the use of foods such as meat, eggs, wheat and beans , in addition to the use of metabolic preparations rich in amino acids, vitamins and minerals
SUS integrates new treatments for rare diseases
"Discussions were held with health professionals and specialists in National Commission for the incorporation of new technologies in SUS (Conitec), "said the ministry, by way of note. "In addition, the observations and suggestions of the population, which represents the majority of patients and relatives of patients with the disease, have also been taken into account."
See more: Know the most common rare diseases in Brazil
Phenylketonuria has a genetic inheritance and causes the unborn individual without important enzyme (phenylalanine-hydroxylase), which prevents the body from functioning properly for break down the amino acid molecules present in animal and plant proteins (phenylalanine-FAL). The high levels of this amino acid in the body and its badociated substances exert a toxic effect on various organs, especially the brain.
Figures
According to data from the Brazilian Society of Pediatrics, 12,000 live births are diagnosed with phenylketonuria. The disease is identified from the birth of the child by the foot test. The test identifies five other diseases: conbad hypothyroidism, sickle cell disease and other hemoglobinopathies, cystic fibrosis, conbad adrenal hyperplasia and biotinidase deficiency.
Find out why the neonatal test is so important:
Source link
